John L. Knopf, CEO and President at ACCELERON PHARMA INC (XLRN), sold 15,500 shares at $34.80 ($541K) on 2015-04-07, disclosed to the SEC on 2015-04-08.
Scheduled sale ($541k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.75 | 7,900 | $275K | 50.8% |
| 2 | $34.80 | 4,500 | $157K | 29.0% |
| 3 | $35.39 | 2,100 | $74K | 13.7% |
| 4 | $35.43 | 500 | $18K | 3.3% |
| 5 | $35.45 | 500 | $18K | 3.3% |
| Total | $34.90 avg | 15,500 |
| $541K |
| 100% |
| Filing → |
| XLRN | SELL | 2016-05-20 | $3.3M | — | Filing → |
| XLRN | SELL | 2015-10-09 | $463K | — | Filing → |
| XLRN | SELL | 2015-09-10 | $574K | — | Filing → |